PINL:GRPOF - Post by User
Comment by
FormerSupporteron Jan 01, 2021 1:17am
195 Views
Post# 32206744
RE:RE:RE:RE:The problem with Tetra, and I've been here since 2015
RE:RE:RE:RE:The problem with Tetra, and I've been here since 2015I totally agree that there is no guarantee as to what Tetra will do if REDUVO gets approved by Health Canada. The issues with HED is it was a novelty beverage and definitely outside of Tetra's wheelhouse. Awaye and the Tropican line are health products and OTC DINs which are not really a pharmaceutical drug. Tetra didn't have the marketing dollars and sales staff to focus on this products. REDUVO however is a pharmaceutical DIN and should be 100% what Tetra is all about. The question that i have for Guy which is not clear is what are the resources needed if Health Canada approves the marketing application and how will they run this and thier 3 drug programs. Dilution will have to come but I think much bigger changes need to take place when you go from a biotect pre revenue to a pharma with a drug in the market. Tetra needs to start making those changes in Q1 2021 to be ready to roll out the drug in Q2 2021. Look for those changes and then you might get insight to what Tetra will do with REDUVO.